DNA Quantity and Quality Comparisons between Cryopreserved and FFPE Tumors from Matched Pan-Cancer Samples
Current Oncology · 28.04.2024 · 31 (5) · 2441-2452
DOI: 10.3390/curroncol31050183 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Current Oncology, online erschienen am 28.04.2024. Verfasst von Jeffrey Okojie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology & Physiology, Brigham Young University, Provo, UT 84602, USA. Hauptthemen laut MEDLINE: Cryopreservation, Paraffin Embedding, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Brigham Young University, INBRE PROGRAM NIH.
Abstract (Originalsprache)
Personalized cancer care requires molecular characterization of neoplasms. While the research community accepts frozen tissues as the gold standard analyte for molecular assays, the source of tissue for testing in clinical cancer care comes almost universally from formalin-fixed, paraffin-embedded tissue (FFPE). As newer technologies emerge for DNA characterization that requires higher molecular weight DNA, it was necessary to compare the quality of DNA in terms of DNA length between FFPE and cryopreserved samples. We hypothesized that cryopreserved samples would yield higher quantity and superior quality DNA compared to FFPE samples. We analyzed DNA metrics by performing a head-to-head comparison between FFPE and cryopreserved samples from 38 human tumors representing various cancer types. DNA quantity and purity were measured by UV spectrophotometry, and DNA from cryopreserved tissue demonstrated a 4.2-fold increase in DNA yield per mg of tissue (p-value < 0.001). DNA quality was measured on a fragment microelectrophoresis analyzer, and again, DNA from cryopreserved tissue demonstrated a 223% increase in the DNA quality number and a 9-fold increase in DNA fragments > 40,000 bp (p-value < 0.0001). DNA from the cryopreserved tissues was superior to the DNA from FFPE samples in terms of DNA yield and quality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology & Physiology, Brigham Young University, Provo, UT 84602, USA.
- Department of Biomedical and Pharmaceutical Sciences, Idaho State University, Pocatello, ID 83209, USA.
- Specicare, 690 Medical Park Ln, Gainesville, GA 30501, USA.
- Simmons Center for Cancer Research, Brigham Young University, Provo, UT 84602, USA.
ORCID-Profile: Jeffrey Okojie, Jared J Barrott
Förderung
- NIGMS NIH HHS
- Brigham Young University
- INBRE PROGRAM NIH
- National Institute of General Medical Sciences
- College of Life Sciences at Brigham Young University
Zitieren
APA
Okojie, J., O'Neal, N., Burr, M., Worley, P., Packer, I., Anderson, D., Davis, J., Kearns, B., Fatema, K., Dixon, K., & Barrott, J. J. (2024). DNA Quantity and Quality Comparisons between Cryopreserved and FFPE Tumors from Matched Pan-Cancer Samples. Current Oncology, 31(5), 2441-2452. https://doi.org/10.3390/curroncol31050183
Vancouver
Okojie J, O'Neal N, Burr M, Worley P, Packer I, Anderson D, et al. DNA Quantity and Quality Comparisons between Cryopreserved and FFPE Tumors from Matched Pan-Cancer Samples. Current Oncology. 2024;31(5):2441-2452. doi:10.3390/curroncol31050183
BibTeX
@article{Okojie2024,
author = {Okojie, Jeffrey and O'Neal, Nikole and Burr, Mackenzie and Worley, Peyton and Packer, Isaac and Anderson, DeLaney and Davis, Jack and Kearns, Bridger and Fatema, Kaniz and Dixon, Ken and Barrott, Jared J},
title = {DNA Quantity and Quality Comparisons between Cryopreserved and FFPE Tumors from Matched Pan-Cancer Samples},
journal = {Current Oncology},
year = {2024},
volume = {31},
number = {5},
pages = {2441--2452},
doi = {10.3390/curroncol31050183}
}
EUVIMED